CD8+T cells expressing CD20 populate brain and cerebrospinal fluid in multiple sclerosis

被引:0
|
作者
Blok, K. [1 ,2 ]
Engelenburg, J. [3 ]
Van Puijfelik, F. [4 ]
Hsiao, C. [3 ,5 ]
De Beukelaar, J. [6 ]
Wokke, B. [7 ]
Huitinga, I.
Hamann, J. [3 ,5 ]
Smolders, J. [3 ,8 ]
机构
[1] Erasmus MC, MS Ctr ErasMS, Dept Neurol, Rotterdam, Netherlands
[2] Albert Schweitzer Hosp, Dept Neurol, Dordrecht, Netherlands
[3] Netherlands Inst Neurosci, Neuroimmunol Res Grp, Amsterdam, Netherlands
[4] Erasmus MC, MS Ctr ErasMS, Dept Immunol, Rotterdam, Netherlands
[5] Amsterdam UMC, Dept Expt Immunol, Amsterda, Netherlands
[6] Albert Schweitzer Hosp, Dept Neurol, Dordrecht, Netherlands
[7] Erasmus MC, MS Ctr ErasMS, Dept Neurol, Rotterdam, Netherlands
[8] Erasmus MC, Dept Immunol, MS Ctr ErasMS, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-162
引用
收藏
页码:229 / 229
页数:1
相关论文
共 50 条
  • [21] CD20+T cells in multiple sclerosis
    Schneider, Raphael
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2015, 4 (01) : 58 - 59
  • [22] Target Cell and Tissue Specificity of a Novel CD8-Targeted Fusosome for Direct In Vivo Delivery of CD19 or a CD20 CAR to CD8+T Cells
    Chandra, Sundeep
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 172 - 173
  • [23] Activated CD4+and CD8+T Cell Proportions in Multiple Sclerosis Patients
    Arneth, Borros
    [J]. INFLAMMATION, 2016, 39 (06) : 2040 - 2044
  • [24] CD8+ T cells in multiple sclerosis
    Denic, Aleksandar
    Wootla, Bharath
    Rodriguez, Moses
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (09) : 1053 - 1066
  • [25] Understanding progression in multiple sclerosis through transcriptomics and DNA methylation in CD4+and CD8+T cells
    Fernandes, S.
    Morikawa, H.
    Ewing, E.
    Ruhrmann, S.
    Karanthanasis, N.
    Lagani, V.
    Tsamardinos, I.
    Kockum, I.
    Olsson, T.
    Piehl, F.
    Jagodic, M.
    Tegner, J.
    Gomez-Cabrero, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 189 - 190
  • [26] DNA methylation differences in CD4+and CD8+T cells of multiple sclerosis patients and healthy controls
    Brorson, I. S.
    Rhead, B.
    Quach, H.
    Berg-Hansen, P.
    Berge, T.
    Harbo, H. F.
    Bos, S. D.
    Barcellos, L. F.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 718 - 719
  • [27] EBV-specific CD8+T cells are exhausted and senescent in multiple sclerosis patients
    Angelini, D. F.
    Guerrera, G.
    Ruggieri, S.
    Gargano, F.
    Placido, R.
    Borsellino, G.
    Battistini, L.
    Gasperini, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 177 - 177
  • [28] Ocrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosis
    van Puijfelik, Fabienne
    Blok, Katelijn M.
    Kranenbarg, Romy A. M. Klein
    Rip, Jasper
    de Beukelaar, Janet
    Wierenga-Wolf, Annet F.
    Wokke, Beatrijs
    van Luijn, Marvin M.
    Smolders, Joost
    [J]. BRAIN COMMUNICATIONS, 2023, 6 (01)
  • [29] Identification of brain-reactive CD8+T cells in multiple sclerosis using autologous stem cell-derived brain cells
    Jones, Samuel
    Perriot, Sylvain
    Canales, Mathieu
    Oberholster, Larise
    Gimenez, Marie
    Theaudin, Marie
    Pot, Caroline
    Mathias, Amandine
    Du Pasquier, Renaud
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 488 - 489
  • [30] Current perspectives on the role of CD8+T cells in systemic sclerosis
    Fuschiotti, Patrizia
    [J]. IMMUNOLOGY LETTERS, 2018, 195 : 55 - 60